Publication date: Available online 13 November 2026 Source: Journal of the American Academy of Dermatology Author(s): Yining Zeng, Xiangyi Fan, Jing Yuan, Zengrui Zhang, Junguo Duan
Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226039186?dgcid=rss_sd_all
Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226039186?dgcid=rss_sd_all
“Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System.” Journal of the American Academy of Dermatology.
@article{article55683,
title = {Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226039186?dgcid=rss_sd_all}
}